During the past decade, ICM - Instituto do Coração de Marília conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 5 clinical trials were completed, i.e. on average, 62.5% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 5 clinical trials were completed. i.e. 125% of trials that started reached the finish line.

Out of the total clinical trials conducted in "ICM - Instituto do Coração de Marília" #1 sponsor was "Boehringer Ingelheim" with 3 trials, followed by "Actelion" with 2 trials sponsored, "Bayer" with 2 trials sponsored, "Amgen" with 1 trials sponsored and "Eli Lilly and Company" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "ICM - Instituto do Coração de Marília" #1 collaborator was "Eli Lilly and Company" with 3 trials as a collaborator, "AcitGraph" with 1 trials as a collaborator, "Almac Clinical Technologies, LLC" with 1 trials as a collaborator, "Chiltern International Ltd." with 1 trials as a collaborator and "Covance Central Laboratory Services, LP" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "ICM - Instituto do Coração de Marília" are "Heart Failure" (3 trials), "Atrial Fibrillation" (1 trials), "Coronary Heart Disease (CHD)" (1 trials), "Diabetes Mellitus, Type 2" (1 trials) and "Heart Failure With Preserved Ejection Fraction" (1 trials). Many other conditions were trialed in "ICM - Instituto do Coração de Marília" in a lesser frequency.

Most popular intervention types in "ICM - Instituto do Coração de Marília" are "Drug" (9 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "Empagliflozin" (2 trials), "Apixaban" (1 trials), "Apixaban matching placebo" (1 trials) and "Asundexian (BAY2433334)" (1 trials). Other intervention names were less common.

The vast majority of trials in "ICM - Instituto do Coração de Marília" are 9 trials for "All" genders.

Currently, there are NaN active trials in "ICM - Instituto do Coração de Marília". undefined are not yet recruiting, 2 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in ICM - Instituto do Coração de Marília, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in ICM - Instituto do Coração de Marília, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".